Anna Stierschneider

PhD Student Institut Biotechnologie

  • Stierschneider, A., Neuditschko, B., Colleselli, K., Hundsberger, H., Herzog, F., & Wiesner, C. (2023): Comparative and Temporal Characterization of LPS and Blue-Light-Induced TLR4 Signal Transduction and Gene Expression in Optogenetically Manipulated Endothelial Cells. Cells, 12(697).

     Doi: https://doi.org/10.3390/cells12050697

  • Woess, K.; Sun, Y.; Morio, H.; Stierschneider, A.; Kaufmann, A.; Hainzl, S.; Trattner, L.; Kocher, T.; Tockner, B.; Leb-Reichl, V.; Steiner, M.; Brachtl, G.; South, A.P.; Bauer, J.W.; Reichelt, J.; Furihata, T.; Wally, V.; Koller, U.; Piñón Hofbauer, J. and Guttmann-Gruber, C. (2022): Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer. International Journal of Molecular Sciences, 23 (1): 575.

     Doi: https://doi.org/10.3390/ijms23010575

  • Stierschneider, A., Grünstäudl, P., Colleselli, K., Atzler, J., Klein, C., Hundsberger, H., Wiesner, C. (2021): Light-Inducible Spatio-Temporal Control of TLR4 and NF-κB-Gluc Reporter in Human Pancreatic Cell Line. International Journal of Molecular Sciences, 22(17): 9232.

     Doi: https://doi.org/10.3390/ijms22179232

  • Hundsberger, H., Stierschneider, A., Sarne, V., Ripper, D., Schimon, J., Weitzenböck, H. P., Schild, D., Jacobi, N., Eger, A., Atzler, J., Klein, C. T., & Wiesner, C. (2021): Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models. Molecules (Basel, Switzerland), 26(3): 717.

     Doi: https://doi.org/10.3390/molecules26030717

  • SSun, Y., Piñón Hofbauer, J., Harada, M., Wöss, K., Koller, U., Morio, H., Stierschneider, A., Kitamura, K., Hashimoto, M., Chiba, K., Akita, H., Anzai, N., Reichelt, J., Bauer, J. W., Guttmann-Gruber, C., & Furihata, T. (2018): Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology. Cancer Letters, 433: 107-116.

     Doi: https://doi.org/10.1016/j.canlet.2018.06.032

  • Jacobi, N., Smolinska, V., Seeboeck, R., Stierschneider, A., Klein, C., Hofmann, E., Wiesner, C., Mohr, T., Oender, K., Lechner, P., Kaiser, H., Hundsberger, H., Eger, A. (2017): 3D Anti-Cancer drug discovery models: A promising approach for precision medicine. In IMC Fachhochschule Krems GmbH (Hrsg.), Online-Tagungsband FHK Forschungsforum 2017. Krems: FFH.

  • Jacobi, N., Smolinska, V., Stierschneider, A., Klein, C., Oender, K., Lechner, P., Kaiser, H., Hundsberger, H., Eger, A. (2016): Development of organotypic cancer models for the identification of individualized cancer therapies. In FH des BFI Wien (Hrsg.), Online-Tagungsband FHK Forschungsforum 2016. Wien: FFH.

Zurück zur Übersicht aller Mitarbeiter